05/09/2012 - 3:30pm

The National Community Pharmacists Association wrapped up its three-day NCPA Legislative Conference Wednesday with a rally, the association announced.

05/09/2012 - 2:25pm

The Food and Drug Administration should apply consistent regulatory standards across all biologics, Sandoz plans to state Friday in testimony at an FDA public hearing on draft guidances related to the development of biosimilars.

05/09/2012 - 1:12pm

The Food and Drug Administration may be close to approving a drug for preventing HIV infection, according to published reports.

05/09/2012 - 9:56am

The National Association of Chain Drug Stores announced on Wednesday that it has submitted comments to the U.S. House Ways and Means Subcommittee on Health urging that retail pharmacies remain exempt from the Medicare durable medical equipment competitive bidding program.

05/08/2012 - 1:44pm

An organization that promotes efforts to stop prescription drug abuse announced Tuesday the release of a mobile app that directs users to places where they can safely get rid of unwanted and unused medications.

05/08/2012 - 1:32pm

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

05/08/2012 - 1:26pm

Community pharmacy operators are the "canary in the coal mine" when it comes to federal or state prescription programs, said Douglas Hoey, CEO for the National Community Pharmacists Association, during a press conference held Tuesday afternoon.

05/08/2012 - 11:33am

With epidemic levels of whooping cough reported in the state of Washington that are creating the need for more immunizations resources, Walgreens on Tuesday announced that it is offering immunizations that provide protection against the highly contagious respiratory infection (tetanus/diphtheria/pertussis-Tdap vaccine) at all of its 129 locations statewide.

05/07/2012 - 3:43pm

The National Association of Chain Drug Stores submitted on Monday comments to the Food and Drug Administration regarding its position on the “new paradigm” for a third class of drugs.